Atoom, A.; Alzubi, B.; Barakat, D.; Abu-Gheyab, R.; Ismail-Agha, D.; Al-Kaabneh, A.; Numan, N.
In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. coli. Antibiotics 2025, 14, 603.
https://doi.org/10.3390/antibiotics14060603
AMA Style
Atoom A, Alzubi B, Barakat D, Abu-Gheyab R, Ismail-Agha D, Al-Kaabneh A, Numan N.
In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. coli. Antibiotics. 2025; 14(6):603.
https://doi.org/10.3390/antibiotics14060603
Chicago/Turabian Style
Atoom, Ali, Bayan Alzubi, Dana Barakat, Rana Abu-Gheyab, Dalia Ismail-Agha, Awatef Al-Kaabneh, and Nawfal Numan.
2025. "In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. coli" Antibiotics 14, no. 6: 603.
https://doi.org/10.3390/antibiotics14060603
APA Style
Atoom, A., Alzubi, B., Barakat, D., Abu-Gheyab, R., Ismail-Agha, D., Al-Kaabneh, A., & Numan, N.
(2025). In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. coli. Antibiotics, 14(6), 603.
https://doi.org/10.3390/antibiotics14060603
